Further exacerbation of the AP process inhibited the expression of Nr5a2 and downregulated the expression of β-catenin and TCF-4, which prevented regeneration of acinar cells and maintained more severe pancreatic inflammation. The gene discussed is NR5A2; the disease is alkaline phosphatase measurement.